Year None202320222021202020192018 Aug 17, 2023 Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development Aug 08, 2023 Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results Jun 06, 2023 Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance Jun 01, 2023 Kronos Bio Announces Participation in Upcoming Investor Conferences May 10, 2023 Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results Apr 24, 2023 Kronos Bio Appoints Roger Dansey, M.D., to Board of Directors Apr 11, 2023 Kronos Bio Announces Changes to Board of Directors Mar 15, 2023 Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results Feb 28, 2023 Kronos Bio Announces Participation in 43rd Annual Cowen Health Care Conference Jan 09, 2023 Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology
Aug 17, 2023 Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development
Jun 06, 2023 Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance
Mar 15, 2023 Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results
Jan 09, 2023 Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology